EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy

Brandon K Hill iD, Andrea M Prinzi iD, J R Kane iD, Amalia K Corby, Barbara D Powe

Open Forum Infectious Diseases · 22.10.2025 · 12 (Supplement_2) · S1404-S1412

DOI: 10.1093/ofid/ofaf444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 22.10.2025. Verfasst von Brandon K Hill und 4 weiteren Autor:innen. Beteiligte Einrichtung: US Medical Affairs, bioMérieux, Salt Lake City, Utah, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: bioMérieux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid and accurate infectious diseases diagnostics are essential to guide antimicrobial stewardship, combat antimicrobial resistance, and improve patient outcomes. However, the availability, adoption, and sustainability of in vitro diagnostics (IVDs) are challenged by high upfront costs, inconsistent coverage and reimbursement policies, and an evolving regulatory landscape. Market access, payor and health policy, and advocacy are pivotal in shaping whether these technologies reach the patient. It is essential to understand the key components of the market access process—regulatory pathways, coverage, reimbursement, evidence generation, and stakeholder engagement—and to recognize how healthcare providers, payors, patients, and policymakers influence diagnostic accessibility. Clinicians, pharmacists, and laboratory professionals must actively participate in advocacy efforts, leveraging clinical insight and evidence to inform regulation, reimbursement, and guideline inclusion. This article presents a practical overview for advancing IVDs through policy and market access engagement, emphasizing the need for coordinated, evidence-based communication with regulatory bodies, payors, and professional societies.

Schlagwörter

Stichwörter der Autor:innen

advocacyhealth policyin vitro diagnosticsinfectious diseases diagnosticsmarket access

Autor:innen und Institutionen

  • US Medical Affairs, bioMérieux, Salt Lake City, Utah, USA.
  • Public Policy and Advocacy, American Society for Microbiology, Washington, District of Columbia, USA.
  • US Market Access, bioMérieux, Salt Lake City, Utah, USA.

ORCID-Profile: Brandon K Hill, Andrea M Prinzi, J R Kane

Förderung

  • bioMérieux

Zitieren

APA

Hill, B. K., Prinzi, A. M., Kane, J. R., Corby, A. K., & Powe, B. D. (2025). Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy. Open Forum Infectious Diseases, 12(Supplement_2), S1404-S1412. https://doi.org/10.1093/ofid/ofaf444

Vancouver

Hill BK, Prinzi AM, Kane JR, Corby AK, Powe BD. Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy. Open Forum Infectious Diseases. 2025;12(Supplement_2):S1404-S1412. doi:10.1093/ofid/ofaf444

BibTeX
@article{Hill2025,
  author = {Hill, Brandon K and Prinzi, Andrea M and Kane, J R and Corby, Amalia K and Powe, Barbara D},
  title = {Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy},
  journal = {Open Forum Infectious Diseases},
  year = {2025},
  volume = {12},
  number = {Supplement_2},
  pages = {S1404--S1412},
  doi = {10.1093/ofid/ofaf444}
}
Kostenlos starten →